Fuji Promotes ORAC Value of AstaREAL®
September 23, 2010
BURLINGTON, Vt.Fuji Health Science announced its AstaREAL® astaxanthin has been shown to have a Total ORAC average value of 24,857 mole TE/g with tests ranging from 21,915 to 28,222 mole TE/g. The Total ORAC tests include testing for five different major oxidative radicals.
AstaREAL, a registered trademark of Fuji Chemical Industry Co. Ltd., has also been the subject of more than 30 different antioxidant studies, including model assay systems, in vitro culture studies, model membrane studies, preclinical in vivo studies and five human clinical. Fuji holds seven patents for astaxanthin in human health applications, with numerous patents pending. AstaREAL is affirmed GRAS (generally recognized as safe) with FDA notification.
Fuji Health Science will have further information on AstaREAL available at SupplySide West, Booth #17022.
You May Also Like